Safety and Influenza Infections in Children Aged 6–35 Months Receiving Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine During the 2023–2024 Influenza Season in South Korea
This study demonstrated a tolerable safety profile and the pattern of influenza infections following SKYCellflu<sup>®</sup> vaccination. Additionally, the two-dose regimen was associated with a lower incidence of influenza infections, suggesting potential benefits in enhancing protection among infants aged 6-11 months.
Authors
- Hye‐Eun Lee (ORCID: https://orcid.org/0000-0003-4648-5042)
- Ju Hwan Kim (ORCID: https://orcid.org/0000-0001-7253-6515)
- Seong‐Beom Park (ORCID: https://orcid.org/0000-0002-8482-9195)
- Hye Young Kim (ORCID: https://orcid.org/0000-0001-9939-3737)
- Ji Young Park (ORCID: https://orcid.org/0000-0002-6777-0494)
- Kyungyeon Jung
- Siyeon Baik
Institutions
- Korea University (KR)
- Ansan University (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Vaccines
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3390/vaccines13050501
- Citations
- 2
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71